Evaluation of Cardiovascular Disease Risk in HIV-1–Infected Patients Treated with Darunavir

INTRODUCTION: We evaluated cardiovascular disease (CVD) risk associated with darunavir treatment and examined the demographic/clinical characteristics of darunavir users based on data from Janssen-sponsored clinical trials, post-marketing pharmacovigilance databases, and administrative claims databa...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Drugs R D
Egile Nagusiak: Opsomer, Magda, Dimitrova, Dessislava, Verspeelt, Johan, Purrington, Amy, Mehbob, Abdul, Chavers, Scott, Pai, Helen, Vanveggel, Simon, Luo, Donghan, Brown, Kimberley, Moecklinghoff, Christiane, Nettles, Richard E., Boven, Katia
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Springer International Publishing 2018
Gaiak:
Original Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6131121/
https://ncbi.nlm.nih.gov/pubmed/29992490
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40268-018-0238-8
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak